Composition
- Active ingredients
- CIPAGLUCOSIDASE ALFA-ATGA 105MG
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application BLA761204.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Pombiliti
- Active substance
- cipaglucosidase alfa-atga
- Drug class
- Enzymes
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Amicus Therap US
- Status
- Prescription
- FDA approval
- 28 Sept 2023
- Application
- BLA761204-001
- RxCUI
- 2667441